Literature DB >> 29491046

Centrosomal Abnormalities in Pancreatic Cancer: Molecular Mechanisms and Clinical Implications.

Daniel Ansari1, Carolina Del Pino Bellido1, Monika Bauden1, Roland Andersson2.   

Abstract

The centrosome is the main microtubule-organizing center in human cells. It regulates normal cell-cycle progression and cell division. Aberrations in the number, structure and function of centrosomes have been found to drive genomic instability and tumorigenesis. Pancreatic cancer frequently displays centrosomal aberrations. Supernumerary and abnormal centrosomes are observed in the earliest stages of pancreatic tumor development, and the p53 pathway acts as an initial barrier to the proliferation of cells with extra centrosomes. In this review, we summarize recent advances in the understanding of centrosomal aberrations in pancreatic cancer, focusing on regulatory mechanisms and prospects for future anticancer treatment. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Centrosomal abnormalities; molecular mechanisms; pancreatic cancer; review; treatment

Mesh:

Substances:

Year:  2018        PMID: 29491046     DOI: 10.21873/anticanres.12345

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  KIF24 depletion induces clustering of supernumerary centrosomes in PDAC cells.

Authors:  Yu Mashima; Hayato Nohira; Hiroki Sugihara; Brian David Dynlacht; Tetsuo Kobayashi; Hiroshi Itoh
Journal:  Life Sci Alliance       Date:  2022-07-08

Review 2.  E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.

Authors:  Santina Venuto; Giuseppe Merla
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

3.  Imidazo[2,1-b]thiazole-Coupled Natural Noscapine Derivatives as Anticancer Agents.

Authors:  Praveen Kumar Reddy Nagireddy; Vamsi Krishna Kommalapati; Vagolu Siva Krishna; Dharmarajan Sriram; Anjana Devi Tangutur; Srinivas Kantevari
Journal:  ACS Omega       Date:  2019-11-05

4.  DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.

Authors:  Meng Cao; Peng-Bo Zhang; Peng-Fei Wu; Qun Chen; Wan-Li Ge; Guo-Dong Shi; Jie Yin; Bao-Bao Cai; Shou-Ji Cao; Yi Miao; Kui-Rong Jiang
Journal:  Biomed Res Int       Date:  2021-03-02       Impact factor: 3.411

5.  Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancer.

Authors:  Radhika R Gudi; Harinarayanan Janakiraman; Philip H Howe; Viswanathan Palanisamy; Chenthamarakshan Vasu
Journal:  Oncotarget       Date:  2021-04-13

Review 6.  Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer.

Authors:  Eid Alshammari; Ying-Xue Zhang; Zhe Yang
Journal:  World J Gastroenterol       Date:  2022-08-07       Impact factor: 5.374

7.  Total Synthesis of Leiodermatolide A via Transfer Hydrogenative Allylation, Crotylation, and Propargylation: Polyketide Construction beyond Discrete Allyl- or Allenylmetal Reagents.

Authors:  Yuk-Ming Siu; James Roane; Michael J Krische
Journal:  J Am Chem Soc       Date:  2021-07-08       Impact factor: 16.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.